Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer - Sara M. Tolaney; Evandro de Azambuja; Kevin Kalinsky; Sherene Loi; Sung-Bae Kim; Clinton Yam; Bernardo Rapoport; Seock-Ah Im; Barbara Pistilli; Wassim Mchayleh; David W. Cescon; Junichiro Watanabe; et al. (New England Journal of Medicine, 2026)